TechWolf BV to be Acquired by SAP SE
Cooley advised TechWolf BV, a leading AI work intelligence platform, on its agreement to be acquired by SAP SE, a global leader in enterprise applications and business AI. Cooley Advised TechWolf BV on Agreement to be Acquired by SAP SE
Glynn Capital Joins Brown Advisory
Cooley advised Glynn Capital, a San Francisco- and Menlo Park-based investment firm with more than 50 years of experience investing in technology companies, on its combination with Brown Advisory, an independent investment management and strategic advisory firm. Glynn Capital Joins Brown Advisory
SoundThinking to be Acquired by Transom Capital Group
Cooley advised SoundThinking, a leading public safety technology company combining transformative solutions and strategic advisory services for law enforcement and civic leadership, on its agreement to be acquired by Transom Capital Group, an operationally focused middle-market private equity firm. Cooley Advised SoundThinking on Agreement to be Acquired by Transom Capital […]
OpenZeppelin to be Acquired by S&P Global
Cooley advised OpenZeppelin, the security standard for onchain finance, on its agreement to be acquired by S&P Global. Cooley Advised OpenZeppelin on Acquisition by S&P Global
Yardi Acquires Sidero Labs
Cooley advised Yardi, a leading provider of software solutions for real estate companies of all types and sizes worldwide, on its acquisition of Sidero Labs, the company behind Talos Linux, the secure open-source operating system for Kubernetes, and Omni, its fleet management platform. Cooley Advised Yardi on Acquisition of Sidero […]
Chimagen Biosciences Agreement to Sell Asset to GSK for Up to $750 Million
Cooley advised Chimagen Biosciences, a privately held biotechnology company, on the agreement to sell a potential best-in-class trispecific T cell-engager (TCE) to GSK. Cooley advised Chimagen Biosciences on Agreement to Sell Asset to GSK for Up to $750 Million
Virtue AI Acquired by Fortinet
Cooley advised Virtue AI, an innovator in AI runtime protection, automated AI validation, and security for autonomous AI systems, on its acquisition by Fortinet, the global cybersecurity leader driving the convergence of networking and security. Cooley Advised Virtue AI on Acquisition by Fortinet
Ambros Therapeutics $550 Million Merger With Werewolf Therapeutics
Cooley advised Ambros Therapeutics, a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with high unmet medical need, on its definitive merger agreement with Werewolf Therapeutics for approximately $550 million. In connection with the transaction, Cooley also advised Ambros Therapeutics on a concurrent private […]
Lynk Global Merger with Omnispace
Cooley advised Lynk Global on its merger with Omnispace and the formation of Elveo Mobile, the newly combined company that delivers mobile connectivity and elevated intelligence for a planet on the move. In connection with the transaction, Cooley also advised Elveo Mobile on two concurrent strategic investments and collaborations from […]
Slate Medicines to Merge With Fulcrum Therapeutics
Cooley advised Slate Medicines, a biotechnology company developing next-generation therapeutics for the treatment of migraine, on its definitive agreement to combine with Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, in an all-stock reverse merger transaction. Slate Medicines to Merge With Fulcrum Therapeutics